TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Letters To the Editor: NCI director Broder responds To Kopans On Mammography October 8, 1993
TCL Archive NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer June 28, 2002
TCL Archive NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers January 15, 1993
